Antimuscarinics have remained the standard of care for patients with overactive bladder (OAB) syndrome for several decades, despite the fact that, owing to their adverse effects, these drugs are ...

Sept. 20, 2005 (Atlanta) — Results from the STAR trial, comparing two new-generation antimuscarinics solifenacin and tolterodine extended release (ER), suggest that solifenacin is superior in reducing ...

A scientist at the University of Buffalo used an FDA-approved drug and human stem cells to increase the production of myelin in a myelin-deficient mouse model. The research (“Anti-Muscarinic Adjunct ...

Review the side-effects of Solifenacin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Solifenacin (Bispec (5 mg)) is a urinary antispasmodic agent, prescribed for overactive bladder with or without incontinence.It works by blocking the action of certain chemicals in the body to help ...

Astellas Pharma announced results from the Phase 3b BESIDE trial of solifenacin (SOLI) with mirabegron (MIRA) as an add-on therapy in incontinent overactive bladder (OAB) patients. The BESIDE study is ...

Patients with overactive bladders who took part in a multi-centre study to measure the effectiveness of solifenacin noticed improvements in as little as three days, according to new research. Patients ...

PARIS—Patients with severely bothersome overactive bladder (OAB) symptoms who have failed treatment with tolterodine ER may benefit by switching to solifenacin, research suggests. At the Société ...

Do not use if you have ever had an allergic reaction to SOLIFENACIN VIATRIS or any of the ingredients listed at the end of the CMI. There are a number of circumstances in which a person should not use ...

As we’re rapidly approaching the middle of the year, it’s a great time to look ahead at where we’re going and the Solifenacin Succinate market Trends we’re likely to see more of in 2020. This report ...